ID   KUMCi002-A
AC   CVCL_A9YG
SY   MM_CD34+iPSCs; MMCD34+_iPSCs
DR   BioSamples; SAMEA7462430
DR   hPSCreg; KUMCi002-A
DR   Wikidata; Q102114442
RX   PubMed=33142253;
CC   From: Korea University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=33142253
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D18S51: 13,17
ST   D19S433: 14.2,15.2
ST   D21S11: 30
ST   D2S1338: 18
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 23,25
ST   TH01: 6,10
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
RX   PubMed=33142253; DOI=10.1016/j.scr.2020.102030;
RA   Lee S.-J., Kim J.-H., Kang K.-W., Lee B.-H., Kim B.-S.;
RT   "Generation of normal induced pluripotent stem cell line KUMCi002-A
RT   from bone marrow CD34+ cells of patient with multiple myeloma disease
RT   having 13q deletion and IGH translocation.";
RL   Stem Cell Res. 49:102030-102030(2020).
//